pharmaphorum | News & views on pharma and biotech’s evolving …
Pills and polls: What the 2024 election means for pharma
1 day ago · President Biden’s passage of the Inflation Reduction Act, which, among many other provisions, allowed Medicare to negotiate drug prices for the first time and set a $35-per …
The evolving role of AI in drug submission and approval: An expert ...
4 days ago · Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and approval processes, and reshaping how researchers identify potential drug …
Deep-Dive | pharmaphorum
5 days ago · Dear Readers, The 2024 US election has cast a long shadow over the pharma industry, with the policies of the next administration poised to reshape drug development, …
Threats impacting the pharmaceutical industry in 2024
1 day ago · Explore the potential threats and risks impacting the pharmaceutical industry in 2024, including considerations such as protests, risk analysis, and the influence of environmental, …
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, …
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
Nov 6, 2024 · Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth …
Deep Dive | A bimonthly magazine for in-depth pharma stories
pharmaphorum presents a bimonthly Deep Dive magazine with extended, visually appealing features on R&D, patients, market access, digital health, and more.
Increasing sustainability in pharma requires an industry-wide effort
1 day ago · MSD joins PD-1/VEGF push in cancer with LaNova deal. There has been a lot of talk about drugs targeting both PD-1 and VEGF stealing the crown held by MSD's Keytruda in …
News | Timely industry updates for pharma and biotech leaders
pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
